These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A case of IgD myeloma representing a missed biclonal paraproteinemia or isotype switch in a patient previously diagnosed with IgA-lambda myeloma. Chepovetsky J; Chari A; Jagannath S; Ramanthan L Clin Chim Acta; 2013 Oct; 425():233-5. PubMed ID: 23954772 [TBL] [Abstract][Full Text] [Related]
24. Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study. Bourhis JH; Bouko Y; Koscielny S; Bakkus M; Greinix H; Derigs G; Salles G; Feremans W; Apperley J; Samson D; Björkstrand B; Niederwieser D; Gahrton G; Pico JL; Goldschmidt H; Haematologica; 2007 Aug; 92(8):1083-90. PubMed ID: 17640853 [TBL] [Abstract][Full Text] [Related]
25. Extramedullary progression of multiple myeloma despite concomitant medullary response to multiple combination therapies and autologous transplant: a case report. Kumar AK; Dakhil C; Teeka Satyan M; Haideri N J Med Case Rep; 2014 Sep; 8():299. PubMed ID: 25200389 [TBL] [Abstract][Full Text] [Related]
26. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma. Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493 [TBL] [Abstract][Full Text] [Related]
28. The current status of hematopoietic stem cell transplantation for multiple myeloma. Bensinger WI Clin Adv Hematol Oncol; 2004 Jan; 2(1):46-52. PubMed ID: 16163159 [TBL] [Abstract][Full Text] [Related]
29. Predictive factors for successful salvage high-dose therapy in patients with multiple myeloma relapsing after autologous blood stem cell transplantation. Fenk R; Liese V; Neubauer F; Bruns I; Kondakci M; Balleisen S; Saure C; Schröder T; Haas R; Kobbe G Leuk Lymphoma; 2011 Aug; 52(8):1455-62. PubMed ID: 21657961 [TBL] [Abstract][Full Text] [Related]
30. Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect. Alyea E; Weller E; Schlossman R; Canning C; Mauch P; Ng A; Fisher D; Gribben J; Freeman A; Parikh B; Richardson P; Soiffer R; Ritz J; Anderson KC Bone Marrow Transplant; 2003 Dec; 32(12):1145-51. PubMed ID: 14647268 [TBL] [Abstract][Full Text] [Related]
31. Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network. Ozaki S; Harada T; Saitoh T; Shimazaki C; Itagaki M; Asaoku H; Kuroda Y; Chou T; Yoshiki Y; Suzuki K; Murakami H; Hayashi K; Mina R; Palumbo A; Shimizu K; ; Acta Haematol; 2014; 132(2):211-9. PubMed ID: 24662986 [TBL] [Abstract][Full Text] [Related]
32. Non-cryopreserved peripheral blood stem cells autologous transplantation in multiple myeloma: Bicentric study. Jennane S; Hasnaoui N; Mahtat EM; Merimi F; Bougar S; El Maaroufi H; Belmekki A; Zafad S; Essakalli M; Mikdame M; Doghmi K Transfus Clin Biol; 2020 Aug; 27(3):152-156. PubMed ID: 32334934 [TBL] [Abstract][Full Text] [Related]
33. Transplantation as salvage therapy for high-risk patients with myeloma in relapse. Lee CK; Barlogie B; Zangari M; Fassas A; Anaissie E; Morris C; Van Rhee F; Cottler-Fox M; Thertulien R; Muwalla F; Mazher S; Badros A; Tricot G Bone Marrow Transplant; 2002 Dec; 30(12):873-8. PubMed ID: 12476279 [TBL] [Abstract][Full Text] [Related]
34. Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders. Kumar SK; Dingli D; Lacy MQ; Dispenzieri A; Hayman SR; Buadi FK; Rajkumar SV; Litzow MR; Gertz MA Br J Haematol; 2008 Apr; 141(2):205-11. PubMed ID: 18318761 [TBL] [Abstract][Full Text] [Related]
36. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation. Dogaru M; Lazăr V; Coriu D Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807 [TBL] [Abstract][Full Text] [Related]
37. Detection of intracellular IgD using flow cytometry could be a novel and supplementary method to diagnose IgD multiple myeloma. Wang W; Zhang CX; Li ZL; Gong M; Ma YG BMC Cancer; 2018 Jun; 18(1):650. PubMed ID: 29890944 [TBL] [Abstract][Full Text] [Related]
39. Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Avet-Loiseau H; Garand R; Lodé L; Harousseau JL; Bataille R; Blood; 2003 Feb; 101(4):1570-1. PubMed ID: 12393502 [TBL] [Abstract][Full Text] [Related]
40. Autologous stem cell transplantation in multiple myeloma: Post-transplant outcomes of Taiwan Blood and Marrow Transplantation Registry. Huang TC; Huang SY; Yao M; Lin CY; Hwang WL; Gau JP; Tan TD; Wang PN; Liu YC; Lin SC; Kao RH; Pei SN; Yu MS; Lin HY; Su YC; Chen CC; Li SS; Wu YY J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):471-480. PubMed ID: 30119948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]